Skip to main content
Erschienen in: Acta Diabetologica 3/2015

01.06.2015 | Original Article

Influence of the glycation gap on the diagnosis of type 2 diabetes

verfasst von: Santiago Rodriguez-Segade, Javier Rodriguez, José M. García-López, Felipe F. Casanueva, Ian C. Coleman, Carmen Alonso de la Peña, Félix Camiña

Erschienen in: Acta Diabetologica | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Aims

The results of using HbA1C-based criteria for diagnosis of type 2 diabetes and prediabetes have been reported to differ from those obtained using fasting plasma glucose (FPG) or an oral glucose tolerance test (OGTT). We aimed to determine whether these discrepancies might be due to the influence of the glycation gap.

Methods

For 430 patients without previously diagnosed diabetes for whom an OGTT had been requested in normal clinical practice, FPG, fructosamine and HbA1C were measured at the time of the test and again 1 month later. Glycaemia/diabetes status was classified as normoglycaemia, prediabetes or diabetes using both HbA1C-based and FPG/OGTT-based criteria, and their glycation gaps GG were calculated.

Results

The specificity of an HbA1C level of 6.5 % (48 mmol/mol) for diagnosis of FPG/OGTT-defined type 2 diabetes was 99 %, but its sensitivity was less than 37 %. HbA1C-diabetic patients had higher average blood glucose levels than FPG/OGTT-diabetic patients. With either set of criteria, high-GG patients were disproportionately numerous among those classified as diabetic and were disproportionately infrequent among those classified as normoglycaemic, but the effect was greater for the HbA1C criteria.

Conclusions

The differences between HbA1C-based and FPG/OGTT-based diagnoses are largely due to the influence of the glycation gap, which may also influence the early stages of FPG/OGTT-defined diabetes.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat American Diabetes Association (2012) Standards of medical care in diabetes. Diabetes Care 35(Suppl 1):S11–S63 American Diabetes Association (2012) Standards of medical care in diabetes. Diabetes Care 35(Suppl 1):S11–S63
4.
Zurück zum Zitat The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183–1197 The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183–1197
5.
Zurück zum Zitat Genuth S, Alberti KG, Bennett P et al (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160–3167CrossRefPubMed Genuth S, Alberti KG, Bennett P et al (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160–3167CrossRefPubMed
9.
Zurück zum Zitat Lipska KJ, De Reheneire N, Van Ness PT, Johnson KC, Kanaya A, Koster A, Strotmeyer ES, Goodpaster BH, Harris T, Gill TM, Inzucchi SE (2010) Identifying dysglycaemic states in older adults: implications of the emerging use of haemoglobin HbA1c. J Clin Endocrinol Metab 95:5289–5295CrossRefPubMedCentralPubMed Lipska KJ, De Reheneire N, Van Ness PT, Johnson KC, Kanaya A, Koster A, Strotmeyer ES, Goodpaster BH, Harris T, Gill TM, Inzucchi SE (2010) Identifying dysglycaemic states in older adults: implications of the emerging use of haemoglobin HbA1c. J Clin Endocrinol Metab 95:5289–5295CrossRefPubMedCentralPubMed
10.
Zurück zum Zitat Carson AP, Reynolds K, Fonseca VA, Muntner P (2010) Comparison of HbA1C and fasting glucose criteria to diagnose diabetes among US adults. Diabetes Care 33:95–97CrossRefPubMedCentralPubMed Carson AP, Reynolds K, Fonseca VA, Muntner P (2010) Comparison of HbA1C and fasting glucose criteria to diagnose diabetes among US adults. Diabetes Care 33:95–97CrossRefPubMedCentralPubMed
11.
Zurück zum Zitat Kumar PR, Bhansali A, Ravikiran M, Bhansali S, Dutta P, Thakur JS, Sachdeva N, Bhadada SK, Walia R (2010) Utility of glycated haemoglobin in diagnosing type 2 diabetes mellitus: a community-based study. J Clin Endocrinol Metab 95:2832–2835CrossRefPubMed Kumar PR, Bhansali A, Ravikiran M, Bhansali S, Dutta P, Thakur JS, Sachdeva N, Bhadada SK, Walia R (2010) Utility of glycated haemoglobin in diagnosing type 2 diabetes mellitus: a community-based study. J Clin Endocrinol Metab 95:2832–2835CrossRefPubMed
12.
Zurück zum Zitat Olson DE, Rhee MK, Herrick K, Ziemer DC, Twombly JG, Phillips LS (2010) Screening for diabetes and pre-diabetes with proposed HbA1C-based diagnostic criteria. Diabetes Care 33:2184–2189CrossRefPubMedCentralPubMed Olson DE, Rhee MK, Herrick K, Ziemer DC, Twombly JG, Phillips LS (2010) Screening for diabetes and pre-diabetes with proposed HbA1C-based diagnostic criteria. Diabetes Care 33:2184–2189CrossRefPubMedCentralPubMed
13.
Zurück zum Zitat Pinelli NR, Jantz AS, Martin ET, Jaber LA (2011) Sensitivity and specificity of glycated haemoglobin as a diagnostic test for diabetes and prediabetes in Arabs. J Clin Endocrinol Metab 96:E1680–E1683CrossRefPubMed Pinelli NR, Jantz AS, Martin ET, Jaber LA (2011) Sensitivity and specificity of glycated haemoglobin as a diagnostic test for diabetes and prediabetes in Arabs. J Clin Endocrinol Metab 96:E1680–E1683CrossRefPubMed
14.
Zurück zum Zitat Nowicka P, Santoro N, Liu H, Lartaud D, Shaw MM, Goldberg R, Guandalini C, Savoye M, Rose P, Caprio S (2011) Utility of haemoglobin HbA1C for diagnosing prediabetes and diabetes in obese children and adolescents. Diabetes Care 34:1306–1311CrossRefPubMedCentralPubMed Nowicka P, Santoro N, Liu H, Lartaud D, Shaw MM, Goldberg R, Guandalini C, Savoye M, Rose P, Caprio S (2011) Utility of haemoglobin HbA1C for diagnosing prediabetes and diabetes in obese children and adolescents. Diabetes Care 34:1306–1311CrossRefPubMedCentralPubMed
15.
Zurück zum Zitat James C, Bullard KM, Rolka DB, Geiss LS, Williams DE, Cowie CC, Albright A, Gregg EW (2011) Implications of alternative definitions of prediabetes for prevalence in US adults. Diabetes Care 34:387–391CrossRefPubMedCentralPubMed James C, Bullard KM, Rolka DB, Geiss LS, Williams DE, Cowie CC, Albright A, Gregg EW (2011) Implications of alternative definitions of prediabetes for prevalence in US adults. Diabetes Care 34:387–391CrossRefPubMedCentralPubMed
16.
Zurück zum Zitat Yudkin JS, Forrest RD, Jackson CA, Ryle AJ, Davie SJ, Gould BJ (1990) Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Diabetologia 33:208–215CrossRefPubMed Yudkin JS, Forrest RD, Jackson CA, Ryle AJ, Davie SJ, Gould BJ (1990) Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Diabetologia 33:208–215CrossRefPubMed
17.
Zurück zum Zitat McCarter RJ, Hempe JM, Gomez R, Chalew SA (2004) Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes. Diabetes Care 27:1259–1264CrossRefPubMed McCarter RJ, Hempe JM, Gomez R, Chalew SA (2004) Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes. Diabetes Care 27:1259–1264CrossRefPubMed
18.
Zurück zum Zitat Cohen RM, Holmes YR, Chenier TC, Joiner CH (2003) Discordance between HbA1c and fructosamine: evidence for a glycosylation gap and its relation to diabetic nephropathy. Diabetes Care 26:163–167CrossRefPubMed Cohen RM, Holmes YR, Chenier TC, Joiner CH (2003) Discordance between HbA1c and fructosamine: evidence for a glycosylation gap and its relation to diabetic nephropathy. Diabetes Care 26:163–167CrossRefPubMed
19.
Zurück zum Zitat Rodriguez-Segade S, Rodriguez J, Cabezas-Agricola JM, Casanueva FF, Camiña F (2011) Progression of nephropathy in type 2 diabetes: the glycation gap is a significant predictor after adjustment for glycohaemoglobin (HbA1c). Clin Chem 57:272–278CrossRef Rodriguez-Segade S, Rodriguez J, Cabezas-Agricola JM, Casanueva FF, Camiña F (2011) Progression of nephropathy in type 2 diabetes: the glycation gap is a significant predictor after adjustment for glycohaemoglobin (HbA1c). Clin Chem 57:272–278CrossRef
20.
Zurück zum Zitat Rodriguez-Segade S, Rodriguez J, García-Lopez JM, Casanueva FF, Camiña F (2012) Estimation of the glycation gap in diabetic patients with stable glycaemic control. Diabetes Care 35:2447–2450CrossRefPubMedCentralPubMed Rodriguez-Segade S, Rodriguez J, García-Lopez JM, Casanueva FF, Camiña F (2012) Estimation of the glycation gap in diabetic patients with stable glycaemic control. Diabetes Care 35:2447–2450CrossRefPubMedCentralPubMed
21.
Zurück zum Zitat Nayak AU, Holland MR, Macdonald DR, Nevill A, Singh BM (2011) Evidence for consistency of the glycation gap in diabetes. Diabetes Care 34:1712–1716CrossRefPubMedCentralPubMed Nayak AU, Holland MR, Macdonald DR, Nevill A, Singh BM (2011) Evidence for consistency of the glycation gap in diabetes. Diabetes Care 34:1712–1716CrossRefPubMedCentralPubMed
22.
Zurück zum Zitat Cohen RM, LeCaire TJ, Lindsell CJ, Smith EP, D’Alessio DJ (2008) Relationship of prospective GHb to glycated serum proteins in incident diabetic retinopathy: implications of the glycation gap for mechanism of risk prediction. Diabetes Care 31:151–153CrossRefPubMed Cohen RM, LeCaire TJ, Lindsell CJ, Smith EP, D’Alessio DJ (2008) Relationship of prospective GHb to glycated serum proteins in incident diabetic retinopathy: implications of the glycation gap for mechanism of risk prediction. Diabetes Care 31:151–153CrossRefPubMed
23.
Zurück zum Zitat Nayak AU, Nevill AM, Bassett P, Singh BM (2013) Association of glycation gap with mortality and vascular complications in diabetes. Diabetes Care 36:3247–3253CrossRefPubMedCentralPubMed Nayak AU, Nevill AM, Bassett P, Singh BM (2013) Association of glycation gap with mortality and vascular complications in diabetes. Diabetes Care 36:3247–3253CrossRefPubMedCentralPubMed
24.
Zurück zum Zitat Selvin E, Rawlings AM, Grams M et al (2014) Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. Lancet Diabetes Endocrinol 2(4):279–288CrossRefPubMedCentralPubMed Selvin E, Rawlings AM, Grams M et al (2014) Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. Lancet Diabetes Endocrinol 2(4):279–288CrossRefPubMedCentralPubMed
25.
Zurück zum Zitat Herman WH, Cohen RM (2010) Haemoglobin A1c: teaching a new dog old tricks. Ann Intern Med 152(12):815–817CrossRefPubMed Herman WH, Cohen RM (2010) Haemoglobin A1c: teaching a new dog old tricks. Ann Intern Med 152(12):815–817CrossRefPubMed
26.
Zurück zum Zitat Cosson E, Chiheb S, Cussac-Pillegand C et al (2013) Haemoglobin glycation may partly explain the discordance between HbA1c measurement and oral glucose tolerance test to diagnose dysglycaemia in overweight/obese subjects. Diabetes Metab 39:118–125CrossRefPubMed Cosson E, Chiheb S, Cussac-Pillegand C et al (2013) Haemoglobin glycation may partly explain the discordance between HbA1c measurement and oral glucose tolerance test to diagnose dysglycaemia in overweight/obese subjects. Diabetes Metab 39:118–125CrossRefPubMed
27.
Zurück zum Zitat American Diabetes Association (2013) Diagnosis and classification of diabetes mellitus (Position Statement). Diabetes Care 36(Suppl 1):S67–S74CrossRefPubMedCentral American Diabetes Association (2013) Diagnosis and classification of diabetes mellitus (Position Statement). Diabetes Care 36(Suppl 1):S67–S74CrossRefPubMedCentral
28.
Zurück zum Zitat Hoelzel W, Weykamp C, Jeppsson JO, Miedema K, Barr JR, Goodall I et al (2004) IFCC reference system for measurement of haemoglobin HbA1C in human blood and the National Standardization Schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 50:166–174CrossRefPubMed Hoelzel W, Weykamp C, Jeppsson JO, Miedema K, Barr JR, Goodall I et al (2004) IFCC reference system for measurement of haemoglobin HbA1C in human blood and the National Standardization Schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 50:166–174CrossRefPubMed
29.
30.
Zurück zum Zitat Cosson E, Banu I, Cussac-Pillegand C et al (2013) Glycation gap is associated with macroproteinuria but not with other complications in patients with type 2 diabetes. Diabetes Care 36:2070–2076CrossRefPubMedCentralPubMed Cosson E, Banu I, Cussac-Pillegand C et al (2013) Glycation gap is associated with macroproteinuria but not with other complications in patients with type 2 diabetes. Diabetes Care 36:2070–2076CrossRefPubMedCentralPubMed
31.
Zurück zum Zitat Herman WH, Cohen RM (2012) Racial and ethnic differences in the relationship between HbA1C and blood glucose: implications for the diagnosis of diabetes. J Clin Endocrinol Metab 97:1067–1072CrossRefPubMedCentralPubMed Herman WH, Cohen RM (2012) Racial and ethnic differences in the relationship between HbA1C and blood glucose: implications for the diagnosis of diabetes. J Clin Endocrinol Metab 97:1067–1072CrossRefPubMedCentralPubMed
Metadaten
Titel
Influence of the glycation gap on the diagnosis of type 2 diabetes
verfasst von
Santiago Rodriguez-Segade
Javier Rodriguez
José M. García-López
Felipe F. Casanueva
Ian C. Coleman
Carmen Alonso de la Peña
Félix Camiña
Publikationsdatum
01.06.2015
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 3/2015
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-014-0666-z

Weitere Artikel der Ausgabe 3/2015

Acta Diabetologica 3/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.